Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes

BACKGROUND: The remedē System Pivotal Trial was a prospective, multi-center, randomized trial demonstrating transvenous phrenic nerve stimulation (TPNS) therapy is safe and effectively treats central sleep apnea (CSA) and improves sleep architecture and daytime sleepiness. Subsequently, the remedē S...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Sci Sleep
Auteurs principaux: Costanzo, Maria Rosa, Javaheri, Shahrokh, Ponikowski, Piotr, Oldenburg, Olaf, Augostini, Ralph, Goldberg, Lee R, Stellbrink, Christoph, Fox, Henrik, Schwartz, Alan R, Gupta, Sanjaya, McKane, Scott, Meyer, Timothy E, Abraham, William T
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092633/
https://ncbi.nlm.nih.gov/pubmed/33953626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NSS.S300713
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires